Home
Jubilant Pharmova Ltd Share Price History
Jubilant Pharmova Ltd
NSE : 21 Feb, 2025
966.95-24.1 (-2.4%)
Prev Close
991.0
Open Price
980.0
Bid Price (QTY)
-
Offer Price (QTY)
-
Volume
140010
Today's High / Low
1011.5 / 961.0
52 WK High / Low
1309.9 / 538.0
Market Price of Jubilant Pharmova Ltd
1M
1Y
3Y
5Y
Monitoring Jubilant Pharmova Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.
History Market Price
| Date | Price | Open | High | Low |
|---|
Returns Comparison
1W
1M
3M
6M
1Y
3Y
5Y
10Y
Growth Parameters
| Parameter |  2017 |
|---|---|
| Sales (Cr.) | NaN |
| Sales YoY Gr. | - |
| Adj EPS | 36.89 |
| YoY Gr. | - |
| Net Profit (Cr.) | 575 |
| BVPS | 220.61 |
Key Financial Parameters
| Parameter | 2015 |
|---|---|
| Return on Capital Emp. % | 5.89 |
| Op. Profit Mgn % | 12 |
| Net Profit Mgn % | -1.05 |
| Debt to Equity % | 1.81 |
Latest Shareholding
Promoters Holdings Over Time
About Jubilant Pharmova Ltd
- Jubilant Pharmova Limited, (Formerly known as Jubilant Life Sciences Limited), is an integrated global pharmaceutical and life sciences company engaged in Pharmaceuticals, Life Science Ingredients and Drug Discovery Solutions.
- The Company is engaged in pharmaceuticals, contract research and development services and proprietary novel drugs.
- The pharmaceuticals segment, through wholly owned subsidiary Jubilant Pharma Limited, is engaged in manufacture and supply of Active Pharmaceutical Ingredients (APIs), Solid Dosage Formulations, Radiopharmaceuticals, Allergy Therapy Products and Contract Manufacturing of Sterile Injectables and Non-Sterile Products through 6 US FDA approved manufacturing facilities in India, USA and Canada with a network of over 48 radiopharmacies in the USA. The contract research and development segment provides drug discovery and development services as well as clinical data software and service solutions.
Popular Search
FAQs for Jubilant Pharmova Ltd Share Price History
What are the key events that typically impact Jubilant Pharmova Ltd's share price history?
Key events that impact Jubilant Pharmova Ltd’s share price history include quarterly earnings releases, product launches, leadership changes, economic policies, and geopolitical developments.
How do stock splits affect Jubilant Pharmova Ltd's share price history?
Stock splits reduce the nominal price of Jubilant Pharmova Ltd's shares by increasing the number of outstanding shares, which typically makes the stock more accessible to a broader range of investors. Although the total market value of the company remains unchanged after the split, the split can affect investor perception and liquidity, potentially influencing the share price in the longer term.
How do dividends impact the share price history of Jubilant Pharmova Ltd?
Dividends can influence Jubilant Pharmova Ltd's share price history by typically causing a temporary dip on the ex-dividend date, as the stock price often adjusts to reflect the dividend payout. Over time, the impact of dividends on the share price may be offset by the company's overall financial performance and market conditions.
How do corporate announcements affect Jubilant Pharmova Ltd’s share price history?
Corporate announcements such as mergers, acquisitions, or strategic shifts can lead to significant price changes. Any optimistic development news on Jubilant Pharmova Ltd generally boosts the company’s share price, whereas negative news can lead to a decline in share price.
How can I use technical analysis to understand Jubilant Pharmova Ltd’s share price history?
To understand Jubilant Pharmova Ltd’s share price history using technical analysis, examine charts for patterns such as trends, support, and resistance levels, and apply indicators like moving averages or Relative Strength Index (RSI) to gauge potential future movements. Analyze historical data to identify recurring trends and signals that might suggest how the share price could behave under similar conditions.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
